DesignMedix Receives $525,000 Series B Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=54f2243d-7e02-4528-8116-021baa0e9843 - Date
7/16/2013 - Company Name
DesignMedix - Mailing Address
2828 SW Corbett Ave Portland, OR 97201 - Company Description
DesignMedix is developing drugs to address the large medical need and markets associated with the rise in drug resistance in multiple diseases. Drug resistance is a huge global and national problem and additional drugs are needed to provide therapeutic options for infectious diseases. - Website
http://www.designmedix.com - Transaction Type
Venture Equity - Transaction Amount
$525,000 - Transaction Round
Series B - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation. - M&A Terms
- Venture Investor
Undisclosed
